Status:
COMPLETED
Pain Management During Screening for Retinopathy of Prematurity
Lead Sponsor:
Istanbul Medeniyet University
Conditions:
Retinopathy of Prematurity
Pain Management
Eligibility:
All Genders
22-33 years
Brief Summary
Abstract Background: Screening examinations for retinopathy of prematurity (ROP) is critical to reduce ROP-related vision loss, however, the procedure is painful and uncomfortable, and topical anesthe...
Detailed Description
Retinopathy of prematurity (ROP) is a physiopathological condition that develops upon abnormal proliferation of the retinal veins in neonates, and its pathogenesis is unknown.1 With the advancements i...
Eligibility Criteria
Inclusion
- Preterm infants of ≤32 weeks of gestational
- Preterm infants ≤ 1500 gram of birth weight
Exclusion
- Major congenital abnormalities
- Neurological dysfunction
- Infants who were mechanically ventilated and/or sedated, hemodynamically unstable
- Infants \> 32 weeks of gestational
- The infants whose parents denied consent were also not included.
Key Trial Info
Start Date :
January 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 15 2020
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT04767178
Start Date
January 1 2020
End Date
August 15 2020
Last Update
February 23 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medeniyet University
Istanbul, Turkey (Türkiye), 34674